Have It Three Ways

Novagen's pTriEx-1 vector contains bacterial, insect, and mammalian promoters. When studying protein function, researchers must often express a protein of interest in different systems for different applications. High-yield requirements might call for cloning of the target gene into an Escherichia coli expression vector, whereas subsequent activity studies might benefit from insect or mammalian cell expression. Obtaining the perfect balance between yield and activity may also inspire testing of

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Novagen's pTriEx-1 vector contains bacterial, insect, and mammalian promoters.
When studying protein function, researchers must often express a protein of interest in different systems for different applications. High-yield requirements might call for cloning of the target gene into an Escherichia coli expression vector, whereas subsequent activity studies might benefit from insect or mammalian cell expression. Obtaining the perfect balance between yield and activity may also inspire testing of several different expression systems. Until recently, testing of multiple systems was time consuming, involving cloning and verification of recombinants in each system-specific vector. Novagen, of Madison, Wis., solves this problem with its pTriEx-1 Multisystem Vector, providing three promoters in one convenient vector and eliminating the need to prepare individual constructs.

The pTriEx-1 vector allows high-level gene expression in mammalian, E. coli, and insect cells. The pTriEx-1 vector combines the features of Novagen's popular pET, BacVector™, and BacMam™ expression systems. The pTriEx-1 vector ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies